TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Randomized, Placebo-controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Brief Summary: The purpose of the study is: Find out if patients receiving sorafenib will live longer. Find out if sorafenib has any effect on patient reported outcomes. Find out if sorafenib prevents the growth of or shrinks liver tumors and/or their metastases. Determine the pharmacokinetics (PK) in patients with liver cancer.


Options:
A: Intervention Type: PROCEDURE; Name: chemoembolization ,Radiofrequency ablation; Assigned to Arm(s): N/A
B: Arm Label: Yttrium-90 radioembolization (90Y-RE); Type: ACTIVE_COMPARATOR; Interventions: Drug: 90Y-RE | Arm Label: Transarterial chemoembolization with drug eluting beads; Type: ACTIVE_COMPARATOR; Interventions: Drug: TACE-DEB | Intervention Type: DRUG; Name: TACE-DEB; Assigned to Arm(s): Transarterial chemoembolization with drug eluting beads | Intervention Type: DRUG; Name: 90Y-RE; Assigned to Arm(s): Yttrium-90 radioembolization (90Y-RE)
C: Arm Label: Sorafenib (Nexavar, BAY43-9006) + TACE; Type: EXPERIMENTAL; Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) | Arm Label: Placebo + TACE; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sorafenib (Nexavar, BAY43-9006); Assigned to Arm(s): Sorafenib (Nexavar, BAY43-9006) + TACE | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + TACE
D: Arm Label: Sorafenib (Nexavar, BAY43-9006); Type: EXPERIMENTAL; Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sorafenib (Nexavar, BAY43-9006); Assigned to Arm(s): Sorafenib (Nexavar, BAY43-9006) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0 % AzaSite Compared to Vehicle in the Treatment of Bacterial Conjunctivitis
Brief Summary: The purpose of this study is to evaluate the clinical and microbial efficacy and safety of AzaSite compared to vehicle for bacterial conjunctivitis. Adults and children one year of age and older with bacterial conjunctivitis in at least one eye may be eligible. Subjects will be randomly assigned to receive either 1.0 % AzaSite or Vehicle. Three visits will be required for this study.


Options:
A: Arm Label: Moxifloxacin AF; Type: EXPERIMENTAL; Interventions: Drug: Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5% | Arm Label: Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Other: Moxifloxacin AF Vehicle | Intervention Type: DRUG; Name: Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5%; Assigned to Arm(s): Moxifloxacin AF | Intervention Type: OTHER; Name: Moxifloxacin AF Vehicle; Assigned to Arm(s): Vehicle
B: Arm Label: Besifloxacin; Type: EXPERIMENTAL; Interventions: Drug: Besifloxacin | Arm Label: Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle (Placebo) | Intervention Type: DRUG; Name: Besifloxacin; Assigned to Arm(s): Besifloxacin | Intervention Type: DRUG; Name: Vehicle (Placebo); Assigned to Arm(s): Vehicle
C: Arm Label: ISV-403; Type: EXPERIMENTAL; Interventions: Drug: ISV-403 | Arm Label: Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle | Intervention Type: DRUG; Name: ISV-403; Assigned to Arm(s): ISV-403 | Intervention Type: DRUG; Name: Vehicle; Assigned to Arm(s): Vehicle
D: Arm Label: AzaSite; Type: EXPERIMENTAL; Interventions: Drug: AzaSite | Arm Label: Vehicle; Type: SHAM_COMPARATOR; Interventions: Other: Vehicle | Intervention Type: DRUG; Name: AzaSite; Assigned to Arm(s): AzaSite | Intervention Type: OTHER; Name: Vehicle; Assigned to Arm(s): Vehicle

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment With MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects With Mild Dementia of the Alzheimer's Type
Brief Summary: The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of dosing.


Options:
A: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Celecoxib | Intervention Type: DRUG; Name: Celecoxib; Assigned to Arm(s): A
B: Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: MPC-7869 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: MPC-7869 | Intervention Type: DRUG; Name: MPC-7869; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: MPC-7869; Assigned to Arm(s): 2
D: Intervention Type: DRUG; Name: Naproxen Sodium (Aleve); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Celecoxib (Celebrex); Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Telemedicine Intervention to Improve Depression Care in Rural CBOCs
Brief Summary: We adapted the collaborative care model using telemedicine (e.g., telephone, interactive video, electronic medical records) to support antidepressant therapy initiated by primary care providers in small rural practices and evaluated the effectiveness and cost-effectiveness of telemedicine-based collaborative care.


Options:
A: Arm Label: Integrated Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Behavioral Care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrated Behavioral Care; Assigned to Arm(s): Integrated Behavioral Intervention
B: Arm Label: Machine and NCC; Type: EXPERIMENTAL; Interventions: Other: MD2 machine and nurse care coordination | Arm Label: Medplanner and NCC; Type: EXPERIMENTAL; Interventions: Other: Medplanner and Nurse Care Coordination | Arm Label: Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: MD2 machine and nurse care coordination; Assigned to Arm(s): Machine and NCC | Intervention Type: OTHER; Name: Medplanner and Nurse Care Coordination; Assigned to Arm(s): Medplanner and NCC
C: Arm Label: Multi-PAP intervention; Type: EXPERIMENTAL; Interventions: Other: Multi-PAP, Other: Usual care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Multi-PAP; Assigned to Arm(s): Multi-PAP intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Multi-PAP intervention, Usual care
D: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Telemedicine intervention | Intervention Type: BEHAVIORAL; Name: Telemedicine intervention; Assigned to Arm(s): Arm 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Telemedicine Intervention to Improve Depression Care in Rural CBOCs
Brief Summary: We adapted the collaborative care model using telemedicine (e.g., telephone, interactive video, electronic medical records) to support antidepressant therapy initiated by primary care providers in small rural practices and evaluated the effectiveness and cost-effectiveness of telemedicine-based collaborative care.


Options:
A: Arm Label: Arm 1: Collaborative Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Care Interventions | Arm Label: Arm 2: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Collaborative Care Interventions; Assigned to Arm(s): Arm 1: Collaborative Care Intervention
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmaceutical care program for antidepressant treatment | Intervention Type: BEHAVIORAL; Name: Pharmaceutical care program for antidepressant treatment; Assigned to Arm(s): Intervention Group
C: Arm Label: Arm 1: Depression Collaborative Care; Type: EXPERIMENTAL; Interventions: Other: Depression collaborative care model | Arm Label: Arm 2: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Depression collaborative care model; Assigned to Arm(s): Arm 1: Depression Collaborative Care
D: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Telemedicine intervention | Intervention Type: BEHAVIORAL; Name: Telemedicine intervention; Assigned to Arm(s): Arm 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Telemedicine Intervention to Improve Depression Care in Rural CBOCs
Brief Summary: We adapted the collaborative care model using telemedicine (e.g., telephone, interactive video, electronic medical records) to support antidepressant therapy initiated by primary care providers in small rural practices and evaluated the effectiveness and cost-effectiveness of telemedicine-based collaborative care.


Options:
A: Intervention Type: PROCEDURE; Name: Standard Quality Improvement; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Patient-centered Intervention; Assigned to Arm(s): N/A
B: Arm Label: Collaborative Care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Care Treatment | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care Treatment | Intervention Type: BEHAVIORAL; Name: Collaborative Care Treatment; Assigned to Arm(s): Collaborative Care | Intervention Type: BEHAVIORAL; Name: Usual Care Treatment; Assigned to Arm(s): Usual Care
C: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Telemedicine intervention | Intervention Type: BEHAVIORAL; Name: Telemedicine intervention; Assigned to Arm(s): Arm 1
D: Intervention Type: BEHAVIORAL; Name: Care manager outreach and monitoring; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study to Lower Veterans Blood Pressure: Patient/Physician Intervention
Brief Summary: This four and a half year trial is evaluating both a patient and a provider intervention in a primary care setting among diagnosed hypertensive veterans. The two primary hypotheses are: 1) the proportion of veterans with BP control who receive either the provider-directed decision support or the patient health education and behavioral intervention will be increased by 10% as compared to usual care; and 2) the proportion of veterans with BP control who receive both the provider-directed decision support and the patient health education and behavioral intervention will be increased by 25% as compared to usual care.


Options:
A: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Telephone behavioral education, Behavioral: Computer behavioral education | Intervention Type: BEHAVIORAL; Name: Telephone behavioral education; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Computer behavioral education; Assigned to Arm(s): Arm 1
B: Arm Label: Tele-visit Group; Type: EXPERIMENTAL; Interventions: Behavioral: TR intervention, Behavioral: In-home messaging device. | Arm Label: Usual Care Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: TR intervention; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: In-home messaging device.; Assigned to Arm(s): Tele-visit Group | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care Group
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Device: placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: VISITS + PDA-FIT system | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Device: PDA-FIT System + telephone follow-up | Intervention Type: DEVICE; Name: placebo; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: VISITS + PDA-FIT system; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: PDA-FIT System + telephone follow-up; Assigned to Arm(s): 3
D: Arm Label: CONTROL group; Type: ACTIVE_COMPARATOR; Interventions: Other: Home Monitoring | Arm Label: ACTIVE group; Type: EXPERIMENTAL; Interventions: Other: Home Monitoring | Intervention Type: OTHER; Name: Home Monitoring; Assigned to Arm(s): ACTIVE group, CONTROL group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study to Lower Veterans Blood Pressure: Patient/Physician Intervention
Brief Summary: This four and a half year trial is evaluating both a patient and a provider intervention in a primary care setting among diagnosed hypertensive veterans. The two primary hypotheses are: 1) the proportion of veterans with BP control who receive either the provider-directed decision support or the patient health education and behavioral intervention will be increased by 10% as compared to usual care; and 2) the proportion of veterans with BP control who receive both the provider-directed decision support and the patient health education and behavioral intervention will be increased by 25% as compared to usual care.


Options:
A: Arm Label: CST; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone-based Enhanced Coping Skills Training (CST) | Arm Label: UMC; Type: OTHER; Interventions: Other: Usual Medical Care and COPD education and symptom monitoring (UMC) | Intervention Type: BEHAVIORAL; Name: Telephone-based Enhanced Coping Skills Training (CST); Assigned to Arm(s): CST | Intervention Type: OTHER; Name: Usual Medical Care and COPD education and symptom monitoring (UMC); Assigned to Arm(s): UMC
B: Arm Label: Personal contact (PC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Personal contact (PC) | Arm Label: Interactive technology (IT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive technology (IT) | Intervention Type: BEHAVIORAL; Name: Personal contact (PC); Assigned to Arm(s): Personal contact (PC) | Intervention Type: BEHAVIORAL; Name: Interactive technology (IT); Assigned to Arm(s): Interactive technology (IT)
C: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Telephone behavioral education, Behavioral: Computer behavioral education | Intervention Type: BEHAVIORAL; Name: Telephone behavioral education; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Computer behavioral education; Assigned to Arm(s): Arm 1
D: Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard Care | Arm Label: Extended Care Management; Type: EXPERIMENTAL; Interventions: Other: Extended Care Management | Intervention Type: OTHER; Name: Extended Care Management; Assigned to Arm(s): Extended Care Management | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Well-being Among Veterans Enhancement Study (WAVES)
Brief Summary: In spite of the impact on veteran�s health status and treatment cost, depression is under-diagnosed and under-treated. The goal of this study is to learn how to implement a previously tested, effective collaborative care model for improving the quality of depression care across multiple Veterans Integrated Service Networks (VISNs). To achieve this goal, we are conducting a randomized controlled trial of evidence-based quality improvement (EBQI), a dissemination method that relies on expert design and local implementation of evidence-based practice interventions. We hypothesize that EBQI will result in increased rates of assessment and appropriate management of depression. Results will be useful in designing realistic chronic care programs and performance measures for continuing care improvement.


Options:
A: Arm Label: Arm 1; Type: OTHER; Interventions: Procedure: System level depression care quality improvement | Intervention Type: PROCEDURE; Name: System level depression care quality improvement; Assigned to Arm(s): Arm 1
B: Arm Label: Integrated Collaborative Care Team; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Collaborative Care Team (ICCT) | Arm Label: Treatment as Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as Usual (TAU) | Intervention Type: BEHAVIORAL; Name: Integrated Collaborative Care Team (ICCT); Assigned to Arm(s): Integrated Collaborative Care Team | Intervention Type: OTHER; Name: Treatment as Usual (TAU); Assigned to Arm(s): Treatment as Usual (TAU)
C: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Systems-level intervention to promote colon cancer screening | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Systems-level intervention to promote colon cancer screening; Assigned to Arm(s): Interventional
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Ninos Sanos Familia Sana | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ninos Sanos Familia Sana | Intervention Type: BEHAVIORAL; Name: Ninos Sanos Familia Sana; Assigned to Arm(s): Comparison, Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Well-being Among Veterans Enhancement Study (WAVES)
Brief Summary: In spite of the impact on veteran�s health status and treatment cost, depression is under-diagnosed and under-treated. The goal of this study is to learn how to implement a previously tested, effective collaborative care model for improving the quality of depression care across multiple Veterans Integrated Service Networks (VISNs). To achieve this goal, we are conducting a randomized controlled trial of evidence-based quality improvement (EBQI), a dissemination method that relies on expert design and local implementation of evidence-based practice interventions. We hypothesize that EBQI will result in increased rates of assessment and appropriate management of depression. Results will be useful in designing realistic chronic care programs and performance measures for continuing care improvement.


Options:
A: Intervention Type: BEHAVIORAL; Name: Care manager outreach and monitoring; Assigned to Arm(s): N/A
B: Arm Label: TCSCT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Telepsychiatry-based Culturally Sensitive Collaborative Treatment | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Telepsychiatry-based Culturally Sensitive Collaborative Treatment | Intervention Type: BEHAVIORAL; Name: Telepsychiatry-based Culturally Sensitive Collaborative Treatment; Assigned to Arm(s): TCSCT, Usual Care
C: Arm Label: Arm 1; Type: OTHER; Interventions: Procedure: System level depression care quality improvement | Intervention Type: PROCEDURE; Name: System level depression care quality improvement; Assigned to Arm(s): Arm 1
D: Arm Label: Assistance with Pain Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Assistance with Pain treatment | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Assistance with Pain treatment; Assigned to Arm(s): Assistance with Pain Treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Well-being Among Veterans Enhancement Study (WAVES)
Brief Summary: In spite of the impact on veteran�s health status and treatment cost, depression is under-diagnosed and under-treated. The goal of this study is to learn how to implement a previously tested, effective collaborative care model for improving the quality of depression care across multiple Veterans Integrated Service Networks (VISNs). To achieve this goal, we are conducting a randomized controlled trial of evidence-based quality improvement (EBQI), a dissemination method that relies on expert design and local implementation of evidence-based practice interventions. We hypothesize that EBQI will result in increased rates of assessment and appropriate management of depression. Results will be useful in designing realistic chronic care programs and performance measures for continuing care improvement.


Options:
A: Arm Label: ICC; Type: EXPERIMENTAL; Interventions: Other: Integrated collaborative care | Arm Label: E&R; Type: ACTIVE_COMPARATOR; Interventions: Other: Education and Resources | Intervention Type: OTHER; Name: Integrated collaborative care; Assigned to Arm(s): ICC | Intervention Type: OTHER; Name: Education and Resources; Assigned to Arm(s): E&R
B: Intervention Type: BEHAVIORAL; Name: UNITED Planned Care; Assigned to Arm(s): N/A
C: Arm Label: Arm 1; Type: OTHER; Interventions: Procedure: System level depression care quality improvement | Intervention Type: PROCEDURE; Name: System level depression care quality improvement; Assigned to Arm(s): Arm 1
D: Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-led case management | Intervention Type: BEHAVIORAL; Name: Nurse-led case management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet-based Diabetes Education and Case Management
Brief Summary: This study is comparing the effectiveness of web-based care management to either telephone-based care management or internet access alone, in patients with poorly controlled diabetes mellitus.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Procedure: Web-based care management | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Telephone and face-to-face care management | Arm Label: Arm 3; Type: SHAM_COMPARATOR; Interventions: Procedure: Internet access alone | Intervention Type: PROCEDURE; Name: Web-based care management; Assigned to Arm(s): Arm 1 | Intervention Type: PROCEDURE; Name: Telephone and face-to-face care management; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Internet access alone; Assigned to Arm(s): Arm 3
B: Intervention Type: BEHAVIORAL; Name: Telephonic diabetes care; Assigned to Arm(s): N/A
C: Arm Label: Telemedicine group; Type: EXPERIMENTAL; Interventions: Other: Telemedicine group | Arm Label: Conventional group; Type: PLACEBO_COMPARATOR; Interventions: Other: Conventional group | Intervention Type: OTHER; Name: Telemedicine group; Assigned to Arm(s): Telemedicine group | Intervention Type: OTHER; Name: Conventional group; Assigned to Arm(s): Conventional group
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Electronic feedback system on diabetes care | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Electronic feedback system on diabetes care; Assigned to Arm(s): Intervention

Answer: A